Health Care -

Your samples

  • No items in the basket
  • Add more products View basket View products to order samples

Remove from basket

Are you sure you want to remove from the sample cart?

Your Language

English Português Español
Health Care
Health Care
  • Products and Applications
    • Product Finder
    • Dietary Supplements  
    • Eye, Ear & Nose  
    • Vaccine Adjuvants  
    • Omega 3 API  
    • Oral  
    • Parenteral  
    • Rectal and Vaginal  
    • Topical  
    • Veterinary Health  
      • Formulation Finder

        Formulation Finder

        Browse our range of fully developed formulations for inspiration and guidance.
        View
  • Technical Library
    • Formulation Finder
    • Brochures  
    • Datasheets and MSDS  
    • FDA IID Sheets  
    • Vaccine Adjuvants – Certificates of GMP Compliance  
    • Excipient Information Package  
    • Presentations  
    • Product Overview Sheets  
    • Videos  
    • Webinars  
      • Product Finder

        Product Finder

        Find a product to suit your needs from our high purity excipients portfolio.
        Product Finder
  • Discovery Zone
    • Product Effects
      • SEDDS and SMEDDS  
      • Increased Vaccine Efficacy  
      • Solubilisers and Emulsifiers  
      • Solvents  
      • Penetration Enhancers  
      • Controlled Release  
      • Skin Barrier Repair with Lanolin  
      • Film Forming Polymers  
    • Chemical Industry Helping to Fight COVID-19  
    • Our Technologies
      • Super Refined Excipients  
      • API grade Omega 3  
      • Vaccine Adjuvant Technology  
      • New Drug Delivery Technology – ProSilic®  
    • Emulsifier Selector  
    • Pharmaceutical Solubility Guide  
    • Veterinary Solubility Guide  
    • Leaders in Regulatory Excellence  
    • How We Can Help  
    • Events Calendar
      • Smarter Innovation Through Quality  
      • DDF Summit - March 2021  
      • Product Effects

        Product Effects

        View our product offerings.
        View
  • News
    • Business News  
    • Events  
    • Innovation  
    • Sustainability  
    • Trends  
      • Events Calendar

        Events Calendar

        We will be present at key industry events taking place over the year around the globe.
        Events
  • Contact  
  1. Home
  2. News
  3. 2020
  4. 07
  5. Croda strengthens position in Life Sciences with the acquisition of Avanti Polar Lipids

News categories

  • Business News
  • Events
  • Innovation
  • Sustainability
  • Trends

Croda strengthens position in Life Sciences with the acquisition of Avanti Polar Lipids

Business News, Innovation
6 Jul 2020
Croda International Plc (‘Croda’) today announces that it has agreed to acquire Avanti Polar Lipids, Inc. (‘Avanti’), a knowledge-intensive leader in lipid-based drug delivery technologies for next generation pharmaceuticals. Croda has acquired Avanti for an initial consideration of $185m on a debt and cash-free basis, with an additional earnout of up to $75m based on near-term commercial opportunities using Avanti’s lipid-based solutions.

Avanti, founded in 1967 by Dr. Walter and Rowena Shaw, is a technology-rich business that operates globally from one site in Alabama in the United States of America. Of its 150 employees, more than 100 are in scientific roles, and 29 have PhD qualifications. The know-how and expertise of its people drives the ongoing development of an extensive IP portfolio with the launch of 125 innovative products typically each year.

Avanti creates and makes high-purity polar lipids that are increasingly being used as delivery systems for complex therapeutic drugs and in next-generation mRNA vaccines. These lipid technologies ensure the targeted, controlled and extended release of active pharmaceutical ingredients (APIs), increasing their efficacy and safety. The business provides its world-class products and services to the majority of the leading pharmaceutical companies, as well as to thousands of biotechnology businesses and academic research organisations.

Avanti’s know-how and technology are highly complementary to Croda’s own capabilities in drug delivery systems, vaccine adjuvants and immunotherapy. The acquisition will more than double Croda’s research and development (R&D) capability in drug delivery. Avanti will also provide a new channel to market Croda’s ingredients for early-stage pharmaceutical research in both commercial and academic organisations worldwide. Equally, Avanti will be able to combine its leading position and flexibility in pharmaceutical R&D applications with Croda’s access to global markets, manufacturing expertise and capacity.  

The acquisition is subject to customary US regulatory approvals. On completion, Avanti will continue to operate under its existing brand, led by the current management team. It will become a part of Croda’s Life Sciences sector and sit within the fast-growing Health Care business. The acquisition is being financed by a three-year term loan, maintaining Croda’s strong liquidity.

Steve Foots, Chief Executive Officer of Croda, said:

“We have long admired the Avanti team for their deep scientific know-how and are already working together on high-potential commercial opportunities. With their exciting drug delivery technologies, Avanti is a market leader in a high growth niche of the health care market, serving over 3,000 customers globally. Bringing Avanti’s best-in-class expertise into Croda also significantly enhances our presence across the pharma product lifecycle, including early stage R&D, clinical trials, analysis and formulation. I am confident that Avanti will prove transformative to the capabilities and performance of our Life Sciences sector.”  

Walter Shaw, Chief Executive Officer of Avanti, said:

“Together with Croda, we are delighted to have found the right home for Avanti, which has been a lifetime’s work for my wife, myself and many of the team. This transaction comes at an exciting moment in the development and proven need for our proprietary lipid systems, and Croda’s skills and Avanti’s capabilities are a powerful match. I am convinced that Croda, with its focus on innovation, is the best place for Avanti to realise its global potential.”
 
For more information, please use our online contact form.

Share this page

  • Click to print this page
  • LinkedIn
  • Facebook
  • Click to share this page on twitter
  • Click to email
    Email Address
    Are you human?
Product Finder Search our product database
MSDS Search for a material safety datasheet
Contact Us Contact your local office

Health Care

We at Croda contribute to a healthier world by offering ingredients and formulation expertise which help our pharmaceutical customers get the best performance from their active ingredients.

Follow us on social media
  • Health Care on LinkedIn

Corporate

  • Products and markets
  • Where we operate
  • Current vacancies
  • Annual Report
  • Sustainability Reports
  • GRI Report
Visit our corporate site
© 2021 Croda International Plc
© 2021 Croda International Plc | Terms and Conditions | Privacy Policy | Accessibility statement

About cookies on this site
By continuing to use this website, you agree to the use of cookies. You can find out more details in our Privacy policy.